Page last updated: 2024-09-05

deflazacort and Polymyalgia Rheumatica

deflazacort has been researched along with Polymyalgia Rheumatica in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's9 (75.00)18.2507
2000's2 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coaccioli, S; Giuliani, M; Pinoca, F; Puxeddu, A; Sabatini, C1
Di Munno, O; Imbimbo, B; Mazzantini, M; Milani, S; Occhipinti, G; Pasero, G1
Accardo, S; Caporali, R; Cimmino, MA; Moggiana, G; Montecucco, C1
Accardo, S; Cimmino, MA; Seriolo, B1
Johnsson, B; Krogsgaard, MR; Lund, B1
Krogsgaard, MR; Lund, B; Thamsborg, G2
Carmona Martín, MM; Navarro López, V; Sáez Barcelona, JA1
Gran, JT1
Bruscas Izu, C; Medrano San Ildefonso, M; Simon, L1
Coulton, L; de Broe, M; Doherty, SM; Galloway, J; Gray, RE; Kanis, JA1
Egsmose, C; Jørgensen, S; Krogsgaard, MR; Lund, B1

Reviews

1 review(s) available for deflazacort and Polymyalgia Rheumatica

ArticleYear
Current therapy of polymyalgia rheumatica.
    Scandinavian journal of rheumatology, 1999, Volume: 28, Issue:5

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Humans; Immunosuppressive Agents; Methotrexate; Pain; Polymyalgia Rheumatica; Pregnenediones

1999

Trials

6 trial(s) available for deflazacort and Polymyalgia Rheumatica

ArticleYear
Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens.
    The Journal of rheumatology, 1995, Volume: 22, Issue:8

    Topics: Aged; Anti-Inflammatory Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methylprednisolone; Middle Aged; Polymyalgia Rheumatica; Pregnenediones; Severity of Illness Index; Time Factors; Treatment Outcome

1995
A longterm prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica.
    The Journal of rheumatology, 1995, Volume: 22, Issue:9

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Double-Blind Method; Female; Humans; Male; Polymyalgia Rheumatica; Prednisolone; Pregnenediones; Prospective Studies; Time Factors; Treatment Outcome

1995
Changes in bone mass during low dose corticosteroid treatment in patients with polymyalgia rheumatica: a double blind, prospective comparison between prednisolone and deflazacort.
    Annals of the rheumatic diseases, 1996, Volume: 55, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Double-Blind Method; Female; Humans; Male; Polymyalgia Rheumatica; Prednisolone; Pregnenediones; Prospective Studies; Time Factors

1996
[Bone loss during low dose glucocorticoid treatment in patients with polymyalgia rheumatica. A double-blind, prospective comparison between prednisolone and deflazacort].
    Ugeskrift for laeger, 1997, Jul-21, Volume: 159, Issue:30

    Topics: Aged; Anti-Inflammatory Agents; Bone Density; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Polymyalgia Rheumatica; Prednisolone; Pregnenediones; Time Factors

1997
A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
    Arthritis and rheumatism, 1991, Volume: 34, Issue:3

    Topics: Analysis of Variance; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone and Bones; Calcium; Chronic Disease; Double-Blind Method; Drug Evaluation; Female; Glucose; Humans; Hydrocortisone; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone; Pregnenediones

1991
Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica.
    Calcified tissue international, 1987, Volume: 41, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone; Pregnenediones; Random Allocation; Therapeutic Equivalency

1987

Other Studies

5 other study(ies) available for deflazacort and Polymyalgia Rheumatica

ArticleYear
[Study of lymphocyte subpopulations in chronic autoimmune inflammatory rheumatic diseases. II. Polymyalgia rheumatica: behaviour of lymphocyte subpopulations during treatment with two different corticosteroids].
    Minerva medica, 2005, Volume: 96, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; CD4-CD8 Ratio; CD8-Positive T-Lymphocytes; Female; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Polymyalgia Rheumatica; Prednisone; Pregnenediones; Receptors, Antigen, T-Cell; T-Lymphocyte Subsets

2005
Long term treatment of polymyalgia rheumatica with deflazacort.
    Annals of the rheumatic diseases, 1994, Volume: 53, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Blood Sedimentation; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Pregnenediones; Prospective Studies

1994
Inappropriate modifications of corticosteroid therapy in polymyalgia rheumatica.
    British journal of rheumatology, 1994, Volume: 33, Issue:4

    Topics: Anti-Inflammatory Agents; Female; Humans; Male; Patient Compliance; Polymyalgia Rheumatica; Pregnenediones

1994
Deflazacort versus methylprednisolone in polymyalgia rheumatica.
    The Journal of rheumatology, 1996, Volume: 23, Issue:7

    Topics: Anti-Inflammatory Agents; Humans; Methylprednisolone; Polymyalgia Rheumatica; Pregnenediones

1996
[RS3PE syndrome: report of 11 cases].
    Anales de medicina interna (Madrid, Spain : 1984), 2000, Volume: 17, Issue:9

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Edema; Female; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone; Pregnenediones; Syndrome; Synovitis

2000